AM
AMPH
Market ClosedAmphastar Pharmaceuticals, Inc.
US
1.98K employees
CEO: Yongfeng Zhang
Founded: 2014
$23.04
+$0.00(+NaN%)
Market Cap
1.02B
Beta
0.92
52W Range
N/A
Dividend Yield
0.00%
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Based on PERT weighted analysis (confidence: high), the fair value is $64.33, implying 180.2% upside from current levels. The stock appears significantly undervalued. Financial health scores indicate solid fundamentals (3.6/5). Monte Carlo analysis shows low downside risk (0% of scenarios below current price). Overall, this suggests a compelling buying opportunity at current prices.
Enhanced Football Field Analysis
Loading comprehensive valuation data...
Fetching multi-methodology valuation ranges...
Explore AMPH
AMPH in the Healthcare
Small Cap